News bites
Tablet sticking research
Research is being carried out by I Holland and the UK's University of Nottingham in an attempt to combat the problem of tablet
sticking. The project, Tabletting Science Anti-stick Research, will use sticky excipients and APIs to analyse why one coating
prevents sticking where another does not.
http://PharmTech.com/Sticking
FDA lawsuit dismissed
A US court has denied AstraZeneca's request for a preliminary injunction against FDA. AstraZeneca filed the lawsuit in March
with regards to the antipsychotic medicines Seroquel (quetiapine fumarate) and Seroquel XR, seeking to prevent FDA from granting
final marketing approval to a generic version of quetiapine until December 2012.
http://PharmTech.com/dismissed
GSK's biopharma boost
GlaxoSmithKline will build a new biopharmaceutical manufacturing facility in the UK — the first in the country in almost forty
years. In addition, the company will invest approximately 600 million at other facilities in the UK to increase production
of key APIs. The investments are one of the largest commitments to the UK life-sciences sector in recent years.
http://PharmTech.com/biopharmaboost
Ben Venue's review results
The EMA has recommended that manufacturing processes for two anticancer medicines be transferred from Ben Venue Laboratories
to alternative facilities. The decision follows GMP shortcomings identified at the US-based manufacturer in late 2011, and
marks the end of the EMA's review of medicines produced at the site.
http://PharmTech.com/benvenue
|
